1. Brief Responsibilities of an HS-IRB Member
  2. Brief Responsibilities of an MR-IRB Member
  3. IRB Member FAQs
  4. For IRB Members
  5. Privacy & Confidentiality
  6. IRB Member Newsletter -- Volume 12 (Summer 2019)
  7. IRB Member Newsletter--Volume 11 (Spring 2018)
  8. Study Personnel Financial Conflicts of Interest and HS IRBs Review Guidance
  9. Children as research participants: Regulations
  10. IRB Member Newsletter--Scheduling Special Edition
  11. Initial Review Tips for IRB Members
  12. IRB Member Newsletter--Volume 9 (Summer 2015)
  13. Noncompliance, Protocol Exceptions and Deviations
  14. Pregnant Women, Fetuses and Neonates: Regulations
  15. Genetic Testing or Analysis
  16. IRB Member Newsletter--Volume 10 (Fall 2017)
  17. Scientist Screwed Up? Send 'em to Researcher Rehab (2017)
  18. What do revised U.S. rules mean for human research? (2017)
  19. The Nuremberg Code 70 Years Later (2017)
  20. How to Conduct PRS Review
  21. Making a Motion at IRB Meetings
  22. Reviewing Initial Applications In ARROW
  23. Drugs, Biologics, and Devices: Regulations
  24. Informed Consent Process, Elements, and Waivers
  25. New IRB Members Guide
  26. IRB Member Newsletter--Volume 8 (Winter 2013)
  27. IRB Member Newsletter--Volume 7 (Spring 2013)
  28. Primary Reviewer Guidance for Initial Reviews
  29. Guidance for UW Madison Health Sciences IRB & Minimal Risk IRB Primary Reviewers for Summarizing Initial Review Applications
  30. Overview of the Accreditation Process and UW-Madison's Human Research Protections Program
  31. IRB Member Newsletter--Volume 2 (Winter 2010)
  32. Finding Study-Related Documents in ARROW
  33. Cheat Sheet (w/ screenshots) for Initial Reviews in ARROW
  34. Brief Overview of Regulatory Basis of IRB Authority and Review Responsibilities
  35. IRB Member Newsletter--Volume 1 (Fall 2009)
  36. Continuing Review & Changes of Protocol
  37. Criteria for IRB Approval: 45 CFR 46.111 (DHHS), 21 CFR 56.111 (FDA), and 38 CFR 16.111 (VA)
  38. Belmont Report
  39. IRB Member Newsletter--Volume 5 (Spring/Summer 2012)
  40. How to Conduct a Modification Response Review in ARROW
  41. Unanticipated Problems and Serious Adverse Events
  42. Prisoners: Regulations
  43. Review Processes Other Than Full-Board
  44. IRB Member Newsletter--Volume 6 (Fall 2012)
  45. IRB Member Workspace Navigation Guide for IRB Members
  46. IRB Member Newsletter--Volume 3 (Summer 2011)
  47. How to Conduct a Deferral Response Review in ARROW
  48. IRB Member Newsletter--Volume 4 (Winter 2011/2012)
  49. Meeting Workspace Navigation Guide for IRB Members
  50. Article: Lessons from researcher rehab
  51. Article: A Comprehensive Analysis of MRI Research Risks: In Support of Full Disclosure
  52. Article: For Henrietta Lacks' Famous Cells, New and Unique Protection
  53. Article: Apple's New ResearchKit: 'Ethics Quagmire' or Medical Research Aid?
  54. Article: Disclosure of Financial Relationships to Participants in Clinical Research
  55. Article: Balancing Risks and Benefits in Clinical Trials
  56. Article: Updating Research Oversight for the 21st Century
  57. Article: Pediatric Magnetic Resonance Research and the Minimal-Risk Standard
  58. Article: A Broken Contract
  59. Article: The Importance of Purpose: Moving Beyond Consent in the Societal Use of Personal Health Information
  60. Article: Clinical Trials, Wrapped in Red Tape
  61. Article: How Variability in the Institutional Review Board Review Process Affects Minimal-Risk Multisite Health Services Research
  62. Article: As Data Overflows Online, Researchers Grapple With Ethics
  63. Article: Rx Risks Not Dislosed to Trial Participants
  64. Article: Blood Samples Raise Questions of Privacy
  65. Reviewing IRB Meeting Minutes in ARROW